CRVS - Corvus Pharmaceuticals, Inc.
17.84
0.310 1.738%
Share volume: 876,189
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$17.53
0.31
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-12-2024 | 03-25-2025 | 05-08-2025 | 08-07-2025 | 11-04-2025 | |
| Assets | ||||||||
| Total Assets | 40.084 M | 64.561 M | 58.815 M | 68.907 M | 59.438 M | 89.461 M | 80.474 M | |
| Current Assets | 22.851 M | 48.258 M | 42.921 M | 54.407 M | 45.491 M | 75.780 M | 66.944 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 14.672 M | 32.405 M | 36.971 M | 43.224 M | 39.213 M | 59.716 M | 62.822 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.456 M | 14.841 M | 4.680 M | 8.740 M | 4.999 M | 14.691 M | 2.867 M | |
| Total Non-current Assets | 16.066 M | 15.404 M | 15.187 M | 12.540 M | 12.058 M | 11.794 M | 11.530 M | |
| Property Plant Equipment | 213.000 K | 192.000 K | 171.000 K | 151.000 K | 165.000 K | 249.000 K | 221.000 K | |
| Other Assets | 17.020 M | 16.111 M | 15.723 M | 14.349 M | 13.782 M | 13.432 M | 13.309 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 40.084 M | 64.561 M | 58.815 M | 68.907 M | 59.438 M | 89.461 M | 80.474 M | |
| Total liabilities | 6.720 M | 13.335 M | 46.406 M | 36.339 M | 10.113 M | 9.233 M | 8.706 M | |
| Total current liabilities | 6.720 M | 13.335 M | 46.406 M | 35.402 M | 9.279 M | 8.505 M | 8.074 M | |
| Accounts Payable | 1.609 M | 1.213 M | 1.873 M | 2.582 M | 1.308 M | 3.137 M | 1.974 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 937.000 K | 834.000 K | 728.000 K | 632.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 937.000 K | 834.000 K | 728.000 K | 632.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 33.364 M | 51.226 M | 12.409 M | 32.568 M | 49.325 M | 80.228 M | 71.768 M | |
| Common stock | 375.057 M | 397.261 M | 398.044 M | 430.866 M | 432.396 M | 471.191 M | 472.800 M | |
| Retained earnings | -340.418 M | -344.680 M | -384.897 M | -397.010 M | -381.817 M | -389.815 M | -399.972 M |